Dr. Mario Naranjo-Tovar Provides Perspective to Healio for Article about FDA Approval of Drug to Treat Pulmonary Arterial Hypertension

For a Healio article highlighting the FDA approval of sotatercept, a drug to treat pulmonary arterial hypertension (PAH), Mario Naranjo-Tovar, MD, MHS, Assistant Professor of Thoracic Medicine & Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective on what this decision means for patients, as well as its impact on the future of care for PAH.